Allogene Therapeutics, Inc. (ALLO) Total assets 2019–2025
Allogene Therapeutics, Inc. (ALLO) total assets at each fiscal year-end, per SEC filings.
$415.9MFY2025 · since FY2019: $717.8M → $415.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $415.9M | -24.2% |
| FY2024 | $548.7M | -14.6% |
| FY2023 | $642.8M | -21.8% |
| FY2022 | $821.6M | -21.8% |
| FY2021 | $1.1B | -14.4% |
| FY2020 | $1.2B | +71.1% |
| FY2019 | $717.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice